Dheer Healthcare Private Limited

Tubervac (BCG vaccine):

Uses:

Bacillus calmette-guerin (tubervac 40mg injection) is used for the prevention of tuberculosis in individuals who are not infected with tuberculosis. It is also used for the treatment and to prevent recurrence of bladder cancer.

How it works:

Tubervac 40mg injection belongs to a class of medications called vaccines. It triggers body’s natural defence system and prevents tuberculosis infection. It is also stops the progression of tumors which are located in urinary bladder.

Common side effects:

Frequent urge to urinate, difficulty in urination, injection site redness, swelling of lymph nodes, stomach upset, vomiting, chills, fever.

• Excellent quality
• Very efficient
• High efficacy
• Reasonable prices

Additional Information:

• Item Code: 3

Additional Information:

• Pay Mode Terms: T/T (Bank Transfer)

Pentavac pfs (pentavalent vaccine) supplied by serum institute of india ltd., in a single dose pre-filled syringe (pfs) is a homogeneous liquid containing purified diphtheria and tetanus toxoids, inactivated whooping cough (pertussis) organisms, highly purified, noninfectious particles of hepatitis b surface antigen (hbsag) and hib component as a bacterial subunit vaccine containing highly purified, non-infectious haemophilus influenzae type b (hib) capsular polysaccharide chemically conjugated to a protein (tetanus toxoid). Surface antigen of the hepatitis b virus (hbv) is obtained by culturing genetically engineered hansenula polymorpha yeast cells having the surface antigen gene of the hepatitis b virus. The hepatitis b surface antigen (hbsag) expressed in the cells of hansenula polymorpha using recombinant dna procedures is purified through several chemical steps. Thiomersal is added as preservative. The vaccine meets the requirements of who when tested by the methods outlined in who, trs 786 (1989) and 800 (1990). The hib polysaccharide is prepared from capsular polysaccharide of h. Influenzae type b strain and after activation is coupled to tetanus toxoid.

Features:

• capsular hib polysaccharide (prp)
• Conjugated to tetanus toxid (carrier protien) 10 mcg
• Adsorbed on aluminium phosphate, al+++ 1.25 mg
• Preservative: thiomersal 0.005 %
• Dose: o.5ml by intramuscular injection.
• It is also available in multi-dose vial of 5 ml & without syringe.
• Diphtheria toxoid 20 lf to 30 lf
• Tetanus toxoid 2.5 lf to 10 lf
• B. Pertussis 4 iu
• Hbsag (rdna)
• Purified capsular hib polysaccharide (prp)
• Conjugated to tetanus toxid (carrier protien) 10 mcg
• Adsorbed on aluminium phosphate, al+++ 1.25 mg

It is also available in multi-dose vial of 5 ml & without syringe.

Menomune Injection is a multi dose vaccine for prevention against meningitis disease manufactured by Sanofi Pasteur. Its generic name is Meningococcal polysaccharide. It is advised to be taken by Haj pilgrims. The vaccine is an active immunising agent used to prevent infection by certain groups of meningococcal bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.This information applies only to the meningococcal vaccine used for meningococcal bacteria Groups A, C, Y, and W-135. These groups cause approximately 50% of meningococcal meningitis cases in the U.S. The vaccine will not protect against infection caused by other meningococcal bacteria groups, such as Group B.

Manufacturer: Sanofi

Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia also may die. These diseases are more likely to occur in young children and in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection. Immunisation against meningococcal disease is recommended for persons 2 years of age or older who are at risk of getting the disease because ;

• They have certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection. They are living in, working in, or visiting an area where there is a strong possibility of contracting meningococcal disease.
• Usually a person needs to receive meningococcal vaccine only once. However, additional injections may be needed for young children who remain at high risk for meningococcal disease. Meningococcal polysaccharide vaccine is to be administered only by or under the supervision of your doctor or other health care professional.

Meningococcal polysaccharide also popularly known as Menactraa or Mencevaxa is a vaccine. It is used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. It is manufactured by MNE companies like Sanofi Aventis & Glaxosmithkline. There are other brands available from Indian manufacturers too.